INTERNATIONAL PATENT: INSTITUTE OF CANCER RESEARCH: ROYAL CANCER HOSPITAL, CANCER RESEARCH TECHNOLOGY LIMITED, THE CHANCELLOR MASTERS AND SCHOLARS OF THE UNIVERSITY OF OXFORD FILES APPLICATION FOR "THERAPEUTIC BIFUNCTIONAL AGENTS"

GENEVA, May 18 -- INSTITUTE OF CANCER RESEARCH: ROYAL CANCER HOSPITAL (123 Old Brompton RoadLondon Greater London SW7 3RP), CANCER RESEARCH TECHNOLOGY LIMITED (2 Redman PlaceLondon Greater London E20 1JQ), THE CHANCELLOR MASTERS AND SCHOLARS OF THE UNIVERSITY OF OXFORD (University OfficesWellington SquareOxford Oxfordshire OX1 2JD) filed a patent application (PCT/GB2025/052440) for "THERAPEUTIC BIFUNCTIONAL AGENTS" on Nov 07, 2025. With publication no. WO/2026/099594, the details related to the patent application was published on May 15, 2026.

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Inventor(s): RUSSEL...